These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11957429)

  • 1. [Localized lipohypertrophy during growth hormone therapy].
    Mersebach H; Feldt-Rasmussen UF
    Ugeskr Laeger; 2002 Apr; 164(14):1930-2. PubMed ID: 11957429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
    Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
    Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolving the growth-promoting and metabolic effects of growth hormone: Differential regulation of GH-IGF-I system components.
    Norbeck LA; Kittilson JD; Sheridan MA
    Gen Comp Endocrinol; 2007 May; 151(3):332-41. PubMed ID: 17376444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pulsatile growth hormone administration to the growth-restricted fetal sheep on somatotrophic axis gene expression in fetal and placental tissues.
    Bloomfield FH; van Zijl PL; Bauer MK; Phua HH; Harding JE
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E333-9. PubMed ID: 16507606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
    Yuen KC; Dunger DB
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of body growth and adipose deposition effects of growth hormone in oMt1a-oGH transgenic mice.
    Oberbauer AM; Stiglich C; Murray JD; Keen CL; Fong DL; Smith LB; Cushwa S
    Growth Dev Aging; 2004; 68(1):33-45. PubMed ID: 15307663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and characterization of cDNAs for hormones and/or receptors of growth hormone, insulin-like growth factor-I, thyroid hormone, and corticosteroid and the gender-, tissue-, and developmental-specific expression of their mRNA transcripts in fathead minnow (Pimephales promelas).
    Filby AL; Tyler CR
    Gen Comp Endocrinol; 2007 Jan; 150(1):151-63. PubMed ID: 16970945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone (GH) treatment reduces peripheral thyroid hormone action in girls with Turner syndrome.
    Susperreguy S; Miras MB; Montesinos MM; Mascanfroni ID; Muñoz L; Sobrero G; Silvano L; Masini-Repiso AM; Coleoni AH; Targovnik HM; Pellizas CG
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):629-36. PubMed ID: 17666093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats.
    Granado M; Priego T; Martín AI; Vara E; López-Calderón A; Angeles Villanúa M
    Eur J Pharmacol; 2006 Apr; 536(1-2):204-10. PubMed ID: 16545800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I mRNA and peptide in the human anterior pituitary.
    Jevdjovic T; Bernays RL; Eppler E
    J Neuroendocrinol; 2007 May; 19(5):335-41. PubMed ID: 17425608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases.
    Denko CW; Malemud CJ
    Semin Arthritis Rheum; 2005 Aug; 35(1):24-34. PubMed ID: 16084221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
    Yuen KC; Dunger DB
    Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis.
    Kawachi S; Takeda N; Sasaki A; Kokubo Y; Takami K; Sarui H; Hayashi M; Yamakita N; Yasuda K
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):617-21. PubMed ID: 15625284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
    Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M
    Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
    Lanes R; Jakubowicz S
    J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of type-1 diabetics with insulin-induced lipohypertrophy by liposuction].
    Hauner H; Olbrisch RR
    Dtsch Med Wochenschr; 1994 Mar; 119(12):414-7. PubMed ID: 8143555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a time-resolved fluoroimmunoassay for measuring plasma insulin-like growth factor I (IGF-I) in fish: effect of fasting on plasma concentrations and tissue mRNA expression of IGF-I and growth hormone (GH) in channel catfish (Ictalurus punctatus).
    Small BC; Peterson BC
    Domest Anim Endocrinol; 2005 Feb; 28(2):202-15. PubMed ID: 15713367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.